Serum microRNA-21 as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromes
about
The role of microRNA in myelodysplastic syndromes: beyond DNA methylation and histone modification.Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignanciesMicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies.Abnormal microRNA expression in the course of hematological malignancies
P2860
Serum microRNA-21 as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromes
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Serum microRNA-21 as a potenti ...... s in myelodysplastic syndromes
@ast
Serum microRNA-21 as a potenti ...... s in myelodysplastic syndromes
@en
type
label
Serum microRNA-21 as a potenti ...... s in myelodysplastic syndromes
@ast
Serum microRNA-21 as a potenti ...... s in myelodysplastic syndromes
@en
prefLabel
Serum microRNA-21 as a potenti ...... s in myelodysplastic syndromes
@ast
Serum microRNA-21 as a potenti ...... s in myelodysplastic syndromes
@en
P2093
P2860
P50
P1433
P1476
Serum microRNA-21 as a potenti ...... s in myelodysplastic syndromes
@en
P2093
Dohyu Hwang
Hoi-Kyung Jeung
Hyeuong Joon Kim
Soo Jeong Kim
Yeo-Kyeoung Kim
P2860
P304
P356
10.1371/JOURNAL.PONE.0086933
P407
P577
2014-02-04T00:00:00Z